Popescu, D.; Badescu, M.C.; Rezus, E.; Tanase, D.M.; Ouatu, A.; Dima, N.; Buliga-Finis, O.-N.; Gosav, E.M.; Costin, D.; Rezus, C.
Cardiovascular Risk in Rheumatic Patients Treated with JAK Inhibitors: The Role of Traditional and Emerging Biomarkers in a Pilot Study. J. Clin. Med. 2025, 14, 5433.
https://doi.org/10.3390/jcm14155433
AMA Style
Popescu D, Badescu MC, Rezus E, Tanase DM, Ouatu A, Dima N, Buliga-Finis O-N, Gosav EM, Costin D, Rezus C.
Cardiovascular Risk in Rheumatic Patients Treated with JAK Inhibitors: The Role of Traditional and Emerging Biomarkers in a Pilot Study. Journal of Clinical Medicine. 2025; 14(15):5433.
https://doi.org/10.3390/jcm14155433
Chicago/Turabian Style
Popescu, Diana, Minerva Codruta Badescu, Elena Rezus, Daniela Maria Tanase, Anca Ouatu, Nicoleta Dima, Oana-Nicoleta Buliga-Finis, Evelina Maria Gosav, Damiana Costin, and Ciprian Rezus.
2025. "Cardiovascular Risk in Rheumatic Patients Treated with JAK Inhibitors: The Role of Traditional and Emerging Biomarkers in a Pilot Study" Journal of Clinical Medicine 14, no. 15: 5433.
https://doi.org/10.3390/jcm14155433
APA Style
Popescu, D., Badescu, M. C., Rezus, E., Tanase, D. M., Ouatu, A., Dima, N., Buliga-Finis, O.-N., Gosav, E. M., Costin, D., & Rezus, C.
(2025). Cardiovascular Risk in Rheumatic Patients Treated with JAK Inhibitors: The Role of Traditional and Emerging Biomarkers in a Pilot Study. Journal of Clinical Medicine, 14(15), 5433.
https://doi.org/10.3390/jcm14155433
